Picture of Agios Pharmaceuticals logo

AGIO — Agios Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Agios’ Pyrukynd® (Mitapivat) Approved In The European Union For Adults With Thalassemia

May 22 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:

AGIOS’ PYRUKYND® (MITAPIVAT) APPROVED IN THE EUROPEAN UNION FOR ADULTS WITH THALASSEMIA

Source text: ID:nGNX1bR2gd

Further company coverage: AGIO.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Agios Pharmaceuticals

See all news